# NCR Voyix Corp: financial statements, quarterly

VYX · NYSE · CIK 70866 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vyx.md) · [Financials](/companies/vyx/financials.md) · [Filings](/companies/vyx/filings.md) · [Insiders](/companies/vyx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vyx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [809](/filings/0000070866-25-000010.md) | [796](/filings/0000070866-25-000010.md) | [710](/filings/0000070866-25-000043.md) | [722](/filings/0000070866-25-000078.md) | [708](/filings/0000070866-25-000088.md) | [682](/filings/0000070866-25-000010.md) | [612](/filings/0000070866-26-000017.md) | [660](/filings/0000070866-26-000030.md) | [684](/filings/0000070866-25-000088.md) | [720 d](/filings/0000070866-26-000006.md) | [606](/filings/0000070866-26-000017.md) | [523](/filings/0000070866-26-000030.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | [195](/filings/0000070866-25-000010.md) | [111](/filings/0000070866-25-000010.md) | [138](/filings/0000070866-25-000010.md) | [126](/filings/0000070866-25-000010.md) | [166](/filings/0000070866-25-000010.md) | [149](/filings/0000070866-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [29.0](/filings/0000070866-24-000037.md) | [41.0 d](/filings/0000070866-26-000006.md) | [47.0](/filings/0000070866-25-000043.md) | [44.0](/filings/0000070866-25-000078.md) | [38.0](/filings/0000070866-25-000088.md) | [28.0 d](/filings/0000070866-26-000006.md) | [40.0](/filings/0000070866-26-000017.md) | [32.0](/filings/0000070866-26-000030.md) | [40.0](/filings/0000070866-25-000088.md) | [43.0 d](/filings/0000070866-26-000006.md) | [39.0](/filings/0000070866-26-000017.md) | [30.0](/filings/0000070866-26-000030.md) |
| Selling, general and administrative | $m | [142](/filings/0000070866-24-000037.md) | [231 d](/filings/0000070866-26-000006.md) | [110](/filings/0000070866-25-000043.md) | [116](/filings/0000070866-25-000078.md) | [113](/filings/0000070866-25-000088.md) | [119 d](/filings/0000070866-26-000006.md) | [115](/filings/0000070866-26-000017.md) | [105](/filings/0000070866-26-000030.md) | [111](/filings/0000070866-25-000088.md) | [120 d](/filings/0000070866-26-000006.md) | [110](/filings/0000070866-26-000017.md) | [112](/filings/0000070866-26-000030.md) |
| Operating income | $m | [24.0](/filings/0000070866-25-000010.md) | [(162)](/filings/0000070866-25-000010.md) | [(19.0)](/filings/0000070866-25-000043.md) | [(34.0)](/filings/0000070866-25-000078.md) | [16.0](/filings/0000070866-25-000088.md) | [2.0](/filings/0000070866-25-000010.md) | [(21.0)](/filings/0000070866-26-000017.md) | [13.0](/filings/0000070866-26-000030.md) | [15.0](/filings/0000070866-25-000088.md) | [17.0 d](/filings/0000070866-26-000006.md) | [(19.0)](/filings/0000070866-26-000017.md) | [14.0](/filings/0000070866-26-000030.md) |
| Interest expense | $m | [83.0](/filings/0000070866-24-000037.md) | [37.0 d](/filings/0000070866-26-000006.md) | [39.0](/filings/0000070866-25-000043.md) | [41.0](/filings/0000070866-25-000078.md) | [40.0](/filings/0000070866-25-000088.md) | [14.0 d](/filings/0000070866-26-000006.md) | [15.0](/filings/0000070866-26-000017.md) | [14.0](/filings/0000070866-26-000030.md) | [15.0](/filings/0000070866-25-000088.md) | [16.0 d](/filings/0000070866-26-000006.md) | [15.0](/filings/0000070866-26-000017.md) | [15.0](/filings/0000070866-26-000030.md) |
| Income tax | $m | [187](/filings/0000070866-24-000037.md) | [(16.0) d](/filings/0000070866-26-000006.md) | [(5.0)](/filings/0000070866-25-000043.md) | [10.0](/filings/0000070866-25-000078.md) | [(1.0)](/filings/0000070866-25-000088.md) | [0.0 d](/filings/0000070866-26-000006.md) | [(7.0)](/filings/0000070866-26-000017.md) | [(4.0)](/filings/0000070866-26-000030.md) | [(6.0)](/filings/0000070866-25-000088.md) | [(56.0) d](/filings/0000070866-26-000006.md) | [(39.0)](/filings/0000070866-26-000017.md) | [(1.0)](/filings/0000070866-26-000030.md) |
| Net income | $m | [(129)](/filings/0000070866-24-000037.md) | [(319)](/filings/0000070866-25-000010.md) | [(40.0)](/filings/0000070866-25-000043.md) | [(73.0)](/filings/0000070866-25-000078.md) | [1,082](/filings/0000070866-25-000088.md) | [(11.0)](/filings/0000070866-25-000010.md) | [(17.0)](/filings/0000070866-26-000017.md) | [0.0](/filings/0000070866-26-000030.md) | [(19.0)](/filings/0000070866-25-000088.md) | [98.0 d](/filings/0000070866-26-000006.md) | [(5.0)](/filings/0000070866-26-000017.md) | [2.0](/filings/0000070866-26-000030.md) |
| Diluted EPS | $ per share | [(0.94)](/filings/0000070866-25-000010.md) | [(2.28)](/filings/0000070866-25-000010.md) | [(0.31)](/filings/0000070866-25-000043.md) | [(0.53)](/filings/0000070866-25-000078.md) | [7.41](/filings/0000070866-25-000088.md) | [(0.10)](/filings/0000070866-25-000010.md) | [(0.15)](/filings/0000070866-26-000017.md) | [(0.03)](/filings/0000070866-26-000030.md) | [(0.16)](/filings/0000070866-25-000088.md) | not reported | [(0.06)](/filings/0000070866-26-000017.md) | [(0.01)](/filings/0000070866-26-000030.md) |
| Basic EPS | $ per share | [(0.94)](/filings/0000070866-25-000010.md) | [(2.28)](/filings/0000070866-25-000010.md) | [(0.31)](/filings/0000070866-25-000043.md) | [(0.53)](/filings/0000070866-25-000078.md) | [7.41](/filings/0000070866-25-000088.md) | [(0.10)](/filings/0000070866-25-000010.md) | [(0.15)](/filings/0000070866-26-000017.md) | [(0.03)](/filings/0000070866-26-000030.md) | [(0.16)](/filings/0000070866-25-000088.md) | not reported | [(0.06)](/filings/0000070866-26-000017.md) | [(0.01)](/filings/0000070866-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0000070866-24-000037.md) | [0.3](/filings/0000070866-26-000006.md) | [0.2](/filings/0000070866-25-000043.md) | [0.2](/filings/0000070866-25-000078.md) | [0.8](/filings/0000070866-25-000088.md) | [0.7](/filings/0000070866-26-000006.md) | [0.6](/filings/0000070866-26-000017.md) | [0.3](/filings/0000070866-26-000030.md) | [0.3](/filings/0000070866-25-000088.md) | [0.2](/filings/0000070866-26-000030.md) | [0.2](/filings/0000070866-26-000017.md) | [0.2](/filings/0000070866-26-000030.md) |
| Current assets | $bn | [3.1](/filings/0000070866-24-000014.md) | [1.2](/filings/0000070866-25-000010.md) | [1.2](/filings/0000070866-24-000025.md) | [1.1](/filings/0000070866-24-000031.md) | [1.8](/filings/0000070866-24-000037.md) | [1.7](/filings/0000070866-26-000006.md) | [1.6](/filings/0000070866-25-000043.md) | [1.2](/filings/0000070866-25-000078.md) | [1.3](/filings/0000070866-25-000088.md) | [1.1](/filings/0000070866-26-000030.md) | [1.2](/filings/0000070866-26-000017.md) | [1.1](/filings/0000070866-26-000030.md) |
| Total assets | $bn | [13.2](/filings/0000070866-24-000014.md) | [5.0](/filings/0000070866-25-000010.md) | [5.0](/filings/0000070866-24-000025.md) | [4.8](/filings/0000070866-24-000031.md) | [4.7](/filings/0000070866-24-000037.md) | [4.5](/filings/0000070866-26-000006.md) | [4.3](/filings/0000070866-25-000043.md) | [4.0](/filings/0000070866-25-000078.md) | [4.0](/filings/0000070866-25-000088.md) | [3.9](/filings/0000070866-26-000030.md) | [3.9](/filings/0000070866-26-000017.md) | [3.9](/filings/0000070866-26-000030.md) |
| Current liabilities | $bn | [2.7](/filings/0000070866-24-000014.md) | [1.3](/filings/0000070866-25-000010.md) | [1.3](/filings/0000070866-24-000025.md) | [1.3](/filings/0000070866-24-000031.md) | [1.5](/filings/0000070866-24-000037.md) | [1.4](/filings/0000070866-26-000006.md) | [1.4](/filings/0000070866-25-000043.md) | [1.1](/filings/0000070866-25-000078.md) | [1.1](/filings/0000070866-25-000088.md) | [1.1](/filings/0000070866-26-000030.md) | [1.1](/filings/0000070866-26-000017.md) | [1.0](/filings/0000070866-26-000030.md) |
| Total liabilities | $bn | [11.6](/filings/0000070866-24-000014.md) | [4.7](/filings/0000070866-25-000010.md) | [4.8](/filings/0000070866-24-000025.md) | [4.6](/filings/0000070866-24-000031.md) | [3.4](/filings/0000070866-24-000037.md) | [3.2](/filings/0000070866-26-000006.md) | [3.2](/filings/0000070866-25-000043.md) | [2.8](/filings/0000070866-25-000078.md) | [2.9](/filings/0000070866-25-000088.md) | [2.8](/filings/0000070866-26-000030.md) | [2.8](/filings/0000070866-26-000017.md) | [2.7](/filings/0000070866-26-000030.md) |
| Long-term debt | $bn | [7.4](/filings/0000070866-23-000044.md) | [2.6](/filings/0000070866-25-000010.md) | [2.7](/filings/0000070866-24-000025.md) | [2.6](/filings/0000070866-24-000031.md) | [1.1](/filings/0000070866-24-000037.md) | [1.1](/filings/0000070866-26-000006.md) | [1.1](/filings/0000070866-25-000043.md) | [1.1](/filings/0000070866-25-000078.md) | [1.1](/filings/0000070866-25-000088.md) | [1.1](/filings/0000070866-26-000030.md) | [1.1](/filings/0000070866-26-000017.md) | [1.1](/filings/0000070866-26-000030.md) |
| Short-term borrowings | $bn | [0.1](/filings/0000070866-23-000044.md) | [0.0](/filings/0000070866-25-000010.md) | [0.0](/filings/0000070866-24-000025.md) | [0.0](/filings/0000070866-24-000031.md) | [0.0](/filings/0000070866-24-000037.md) | [0.0](/filings/0000070866-26-000006.md) | [0.0](/filings/0000070866-25-000043.md) | [0.0](/filings/0000070866-25-000078.md) | [0.0](/filings/0000070866-25-000088.md) | [0.0](/filings/0000070866-26-000030.md) | [0.0](/filings/0000070866-26-000017.md) | [0.0](/filings/0000070866-26-000030.md) |
| Shareholders' equity | $bn | [1.4](/filings/0000070866-23-000044.md) | [0.0](/filings/0000070866-25-000010.md) | [(0.0)](/filings/0000070866-24-000025.md) | [(0.1)](/filings/0000070866-24-000031.md) | [1.0](/filings/0000070866-24-000037.md) | [0.9](/filings/0000070866-26-000006.md) | [0.9](/filings/0000070866-25-000043.md) | [0.9](/filings/0000070866-25-000078.md) | [0.8](/filings/0000070866-25-000088.md) | [0.9](/filings/0000070866-26-000030.md) | [0.9](/filings/0000070866-26-000017.md) | [0.9](/filings/0000070866-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [189 d](/filings/0000070866-24-000037.md) | [(33.0) d](/filings/0000070866-26-000006.md) | [(35.0)](/filings/0000070866-25-000043.md) | [62.0 d](/filings/0000070866-25-000078.md) | [11.0 d](/filings/0000070866-25-000088.md) | [(170) d](/filings/0000070866-26-000006.md) | [(42.0)](/filings/0000070866-26-000017.md) | [(242) d](/filings/0000070866-26-000030.md) | [14.0 d](/filings/0000070866-25-000088.md) | [60.0 d](/filings/0000070866-26-000006.md) | [42.0](/filings/0000070866-26-000017.md) | [17.0 d](/filings/0000070866-26-000030.md) |
| Capital expenditure | $m | [42.0 d](/filings/0000070866-24-000037.md) | [18.0 d](/filings/0000070866-25-000010.md) | [8.0](/filings/0000070866-25-000043.md) | [13.0 d](/filings/0000070866-25-000078.md) | [2.0 d](/filings/0000070866-25-000088.md) | [7.0 d](/filings/0000070866-25-000010.md) | [39.0](/filings/0000070866-26-000017.md) | [42.0 d](/filings/0000070866-26-000030.md) | [(62.0) d](/filings/0000070866-25-000088.md) | [146 d](/filings/0000070866-26-000006.md) | [36.0](/filings/0000070866-26-000017.md) | [41.0 d](/filings/0000070866-26-000030.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | [0.0](/filings/0000070866-25-000043.md) | [0.0 d](/filings/0000070866-25-000078.md) | [0.0 d](/filings/0000070866-25-000088.md) | [56.0 d](/filings/0000070866-26-000006.md) | [62.0](/filings/0000070866-26-000017.md) | [7.0 d](/filings/0000070866-26-000030.md) | [0.0 d](/filings/0000070866-25-000088.md) | [5.0 d](/filings/0000070866-26-000006.md) | [9.0](/filings/0000070866-26-000017.md) | [11.0 d](/filings/0000070866-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [140](/filings/0000070866-23-000044.md) | [140](/filings/0000070866-24-000025.md) | [140](/filings/0000070866-24-000031.md) | [141](/filings/0000070866-24-000037.md) | [144](/filings/0000070866-25-000043.md) | [145](/filings/0000070866-25-000078.md) | [145](/filings/0000070866-25-000088.md) | [140](/filings/0000070866-26-000017.md) | [138](/filings/0000070866-26-000030.md) | [138](/filings/0000070866-25-000088.md) | [139](/filings/0000070866-26-000017.md) | [138](/filings/0000070866-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 138,069,898 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0000070866-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.